Mini-Oral Session

[MO17] Mini-Oral Session 17　Gynecologic Cancer
【E】

Thu. Feb 17, 2022 3:10 PM - 4:00 PM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair：Shinichi Okame（Department of Gynecologic Oncology, NHO Shikoku Cancer Center），Shin Nishio（Department of Obstetrics and Gynecology, Kurume University School of Medicine）

+Add all to schedule

[MO17-1] Clinical Practice of Comprehensive Genomic Profiling in Gynecologic Malignancies at National Cancer Center Hospital

^○Yohei Chiba, Kazuki Sudo, Motoko Arakaki, Ayumi Saito, Momoko Tokura, Syu Yazaki, Chiharu Mizoguchi, Hitomi Okuma, Syosuke Kita, Kasumi Yamamoto, Yuki Kojima, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Kan Yonemori (Department of Medical Oncology, National Cancer Center Hospital)

[MO17-2] Withdrawn

[MO17-3] Diagnostic significance of HE4 as a Biomarker in Ovarian Cancer

^○Harshita Dubey (Laboratory Oncology Unit, DR.B.R.A-IRCH, AIIMS, New Delhi)

[MO17-4] Antitumor activity of niraparib for patient-derived xenografts of rare subtypes of ovarian cancer

^○Hiroshi Asano¹, Kanako Hatanaka C^2,3, Megumi Morimoto⁴, Takahito Hara⁴, Yoshihiro Matsuno⁵, Yutaka Hatanaka^2,3, Hidemichi Watari¹ (1.Department of Obstetrics and Gynecology, Hokkaido University, 2.Center for Development of Advanced Diagnostics, Hokkaido University Hospital, 3.Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, 4.Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, 5.Department of Surgical Pathology, Hokkaido University Hospital)

[MO17-5] Clinique characteristics and result of treatment of ovarian clear cell carcinoma in Cancer National Hospital

^○Yen Le (Department Medical Oncology)